These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25381634)

  • 21. Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
    Kanaji N; Tadokoro A; Kita N; Murota M; Ishii T; Takagi T; Watanabe N; Tojo Y; Harada S; Hasui Y; Kadowaki N; Bandoh S
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1855-65. PubMed ID: 27350261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictors of mortality in IPF - Does emphysema change the prognosis?
    Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
    Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
    Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.
    Goto T; Maeshima A; Oyamada Y; Kato R
    Int J Clin Oncol; 2014 Apr; 19(2):266-73. PubMed ID: 23660786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cumulative incidence of and predictive factors for lung cancer in IPF.
    Ozawa Y; Suda T; Naito T; Enomoto N; Hashimoto D; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Chida K
    Respirology; 2009 Jul; 14(5):723-8. PubMed ID: 19659650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced area of the normal lung on high-resolution computed tomography predicts poor survival in patients with lung cancer and combined pulmonary fibrosis and emphysema.
    Miyamoto A; Kurosaki A; Moriguchi S; Takahashi Y; Ogawa K; Murase K; Hanada S; Uruga H; Takaya H; Morokawa N; Fujii T; Hoshino J; Kishi K
    Respir Investig; 2019 Mar; 57(2):140-149. PubMed ID: 30472091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete regression of pulmonary squamous carcinoma in IPF following gemcitabine plus cisplatin: a case report and literature review.
    Ma W; Li H; Tian Z; Wang S; Zheng X; Hou J
    BMC Pulm Med; 2020 Mar; 20(1):69. PubMed ID: 32197657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
    Hata A; Sekine Y; Kota O; Koh E; Yoshino I
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1261-8. PubMed ID: 27354784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
    Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis.
    Bahig H; Filion E; Vu T; Roberge D; Lambert L; Bouchard M; Lavoie C; Doucet R; Nadeau DB; Chalaoui J; Campeau MP
    Technol Cancer Res Treat; 2015 Dec; 14(6):667-76. PubMed ID: 24988054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory bronchiolitis and lung carcinoma.
    Yamada Y; Terada J; Tatsumi K; Kono C; Tanno M; Takemura T; Yamaguchi T
    Respir Investig; 2013 Sep; 51(3):184-90. PubMed ID: 23978645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of lung cancer cases diagnosed in an internal medicine department: from January 2001 to September 2006].
    Fernández V; Alonso JL; Munuera L; Moya JL; Lasa B; Suárez A; Gutiérrez J
    An Sist Sanit Navar; 2007; 30(3):353-62. PubMed ID: 18227892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.
    Kawasaki H; Nagai K; Yoshida J; Nishimura M; Nishiwaki Y
    J Surg Oncol; 2002 Sep; 81(1):33-7. PubMed ID: 12210025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.
    Leuschner G; Reiter F; Stocker F; Crispin A; Kneidinger N; Veit T; Klenner F; Ceelen F; Zimmermann G; Leuchte H; Reu S; Dinkel J; Behr J; Neurohr C
    Lung; 2018 Aug; 196(4):401-408. PubMed ID: 29761229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
    Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
    Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
    Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
    BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
    Kreuter M; Ehlers-Tenenbaum S; Schaaf M; Oltmanns U; Palmowski K; Hoffmann H; Schnabel PA; Heußel CP; Puderbach M; Herth FJ; Warth A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):266-74. PubMed ID: 25591137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.
    Kim H; Pyo H; Noh JM; Lee W; Park B; Park HY; Yoo H
    Radiat Oncol; 2019 Jan; 14(1):19. PubMed ID: 30691496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.